In Medtronic’s spinal sector, revenue from core spinal products, including Kyphon, increased 2 percent and biologics revenue grew 12 percent, both on a constant currency basis.
Outside the United States, the company’s spinal revenue grew 10 percent on a constant currency basis, driven by solid growth everywhere except Europe.
Read the release on Medtronic’s Q3 spinal revenue.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
